News
0
Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy and pipeline”....
0
The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults.
0
Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the financial conditions created by the coronavirus.
0
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the former’s therapeutics in a...
Features
Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry better...
Featured Appointment
StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer.
The newly created role will see...
Service Company News
Featured Event
15/04/2020 - 16/04/2020 -
Philadelphia,
@Pharmafocus
